News
You are here: Home » News » News

News Center

  • Yocon Biotech's GMP Drug Regulation Training Progresses Smoothly, Raising the Bar for Compliant Production

    2025-02-11

    In 2024, with the rapid development of the global pharmaceutical industry and increasingly stringent regulatory requirements, ensuring the quality and safety of drug production has become a core issue that pharmaceutical companies cannot afford to overlook. Cells, as biopharmaceuticals with signific Read More
  • Yocon Biotech's Serum - free Medium for Stem Cells Obtains US FDA Class II Registration

    2025-02-07

    The serum - free medium for stem cells of Yocon Biotech has been approved for 510K Class II medical device registration by the US FDA, with the registration certificate number K232543. It is the second global and the first Chinese registration certificate of this product issued by the US FDA. The se Read More
  • Yocon's GMP - grade Cell Cryopreservation Solution and Stem Cell Mild Digestive Enzyme have been linked and activated in the US FDA.

    2024-07-16

    Recently, Yocon's GMP - grade Cell Cryopreservation Solution (NC1010) and Stem Cell Mild Digestive Enzyme (NC1004) have been successfully linked and activated in the US FDA. This not only means that these two products can support Chinese pharmaceutical companies in applying for the approval of cell Read More
Leave a Message
Contact Us

QUICK LINKS

CONTACT INFO

YOCON BIOTECH COMPANY
 Service hotline: +86-400-001-1266
 Telephone: +86-010-5871-1655
 Email: wangxiaoke@yocon.com.cn
 Address: No. 6 Keji Road, Miyun District, Beijing
Copyright © 2025 YOCON Biotech Company All rights reserved.  Sitemap | Privacy Policy | Support By Leadong